Business Analyst

We are looking for a Business Analyst to join our dynamic and interdisciplinary team to further develop our software, interpret Autolomous clients’ requirements into technical implementations, and play an active role in all areas of the business.

Business Analysts intersect with many elements of our company’s work including Development, Software QA, Configuration and Computer System Validation – either by collaborating within teams or working with colleagues from these groups. You will receive guidance and support as well as frequent coaching and mentoring from peers.

We view the role as the start of a rewarding, challenging, and highly flexible career with Autolomous. Join us to do meaningful work and to never stop learning.

The baseline for our ideal candidate:

    • A strong thinker, creative problem solver and an efficient doer
    • Effective and clear communicator orally and written
    • Has demonstrated aptitude for analytics
    • Can work well in a team but is also independent, self-driven and well organised
    • Eager to learn new technologies
    • Has an entrepreneurial spirit
    • Based in London or commutable distance to London

It’s a plus if you

    • Have a basic understanding of software development
    • Can write and present software requirements and specifications
    • Are familiar with agile / scrum processes
    • Have experience in the healthcare / pharmaceutical industry
    • Have previously used Atlassian products such as Jira and Confluence

Get in touch if you’re interested in working with us – joinus@autolomous.com

Posting end date: July 17, 2021

About us
Autolomous is the market-leading developer of critical manufacturing management systems for advanced therapies. Autolomous internationally deploys fully integrated, digitised and automated supply chain software solutions.
These solutions utilise emerging technologies such as Distributed Ledger technology and the Internet of Things (IoT) to ensure compliance with current and future regulatory requirements e.g. FDA 21 CFR part 11 and EU Annex 11.
As a result, Autolomous enables manufacturers to reduce costs and deliver advanced therapies to more patients. Autolomous’ platform, AutoloMATE®, is a business-critical, robust digital solution increasing efficiency, scalability and process streamlining of GMP manufacturing and product release of advanced therapies.
We have a proven track record on deploying the AutoloMATE® platform to a variety of commercial entities – UCL (Academia), Advent Bioservices (CDMO), Glycostem (Dutch Allogeneic Manufacturer), US CDMO, within industry-leading delivery timelines.
Successfully engaged with the wider CGT ecosystem, having created 5 external system integrations with key suppliers within the CGT industry (Becton Dickinson, Beckman Coulter, Ideagen, Maxcyte, Chemometec).
Autolomous is headquartered in London. The company was founded in 2019 by four professionals with a combined experience covering fifty years in advanced therapies and medical practice and thirty-five years in technology, software and business.